Results 101 to 110 of about 39,263 (231)

RISK FACTORS OF TREATMENT FAILURE AND RECURRENT ENDOMETRIAL HYPERPLASIA IN WOMEN OF REPRODUCTIVE AGE WITH OBESITY

Фундаментальная и клиническая медицина, 2016
Aim: To identify the risk factors for treatment failure and recurrent endometrial hyperplasia in women of reproductive age with obesity. Materials and Methods: We performed a retrospective, case-control study. The study included 92 women
Elena A. Shakirova, Natalia V. Artymuk
doaj  

ENDOMETRIAL PRECANCER: DEFINITION OF CONCEPTS, TACTICS

Акушерство, гинекология и репродукция, 2016
Objective. To substantiate indications for a differential approach in the treatment of patients with atypical endometrial hyperplasia.Materials and Methods.The results of surgical treatment in 132 patients with atypical endometrial hyperplasia have been ...
Iu. Iu. Tabakman, A. G. Solopova, A. Kh. Bishtavi, L. E. Idrisova   +3 more
doaj   +1 more source

Cardiovascular Health in Women—Across the Lifespan

Clinical Endocrinology, Volume 104, Issue 6, Page 539-555, June 2026.
ABSTRACT Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity among women worldwide. However, CVD continues to be perceived as a predominantly male issue. CVD in women therefore remains understudied, underrecognized and undertreated.
Jaya Chandrasekhar, Jessica Yao, Simone Gong, Madhuka Wijayarathne, Monique Watts, Swati Mukherjee   +5 more
wiley   +1 more source

Efficacy and Safety of Fixed‐Dose Combinations of Sitagliptin and Empagliflozin as Add‐On to Metformin in Korean Patients With Type 2 Diabetes: A Randomised, Double‐Blind, Multi‐Centre, Placebo‐Controlled, Phase III Trial

Diabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 4847-4859, June 2026.
ABSTRACT Background Type 2 diabetes mellitus (T2DM) is a progressive, multi‐organ disorder that often requires intensive combination therapy. This Phase III, randomised, double‐blind, placebo‐controlled study evaluated the efficacy and safety of two fixed‐dose combinations (FDCs) of sitagliptin 100 mg with empagliflozin 10 mg (DW1026C1) or ...
Soo Lim, Tae Nyun Kim, Ji Oh Mok, Choon Hee Chung, You Cheol Hwang, Ho Chan Cho, Jong Chul Won, Eonju Jeon, Eun Seok Kang, Ki Young Lee, Chong Hwa Kim, Soo Heon Kwak, Cheol Young Park, Kang Seo Park, Sang Yong Kim, Jae Hyuk Lee, Soon Hee Lee, Dong Hyeok Cho, Hyuk‐Sang Kwon, Kyung Ah Han   +19 more
wiley   +1 more source

Efficacy of Fertility‐Sparing Treatment With Progestin Is Associated With Different Molecular Classification in Endometrial Carcinoma and Atypical Endometrial Hyperplasia

Cancer Medicine, Volume 15, Issue 5, May 2026.
Molecular profiles and outcomes of CR rate in 74 cases. ABSTRACT Objective To investigate the impact of various molecular characteristics on the outcomes of fertility‐preserving therapy in patients with endometrial cancer (EC) and atypical endometrial hyperplasia (AEH).
Xue‐Qian Qian, Hao‐Hui Fu, Xiao‐Yun Wan, Dong‐Xiao Hu, Yuan‐Ming Shen   +4 more
wiley   +1 more source

Benefits of Levonorgestrel Intrauterine Device Use vs. Oral or Transdermal Progesterone for Postmenopausal Women Using Estrogen Containing Hormone Therapy

INNOVATIONS in Pharmacy, 2019
Background: Endometrial hyperplasia is a major concern for women that start estrogen replacement therapy (ERT) to control symptoms experienced during perimenopause and postmenopause.
Kaylee Clark, Sarah M. Westberg
doaj   +1 more source

Carrier screening in the reproductive setting—Are there medical implications for the heterozygote?—A guide for clinicians

Pregnancy, Volume 2, Issue 3, May 2026.
Abstract Carrier screening for genetic conditions performed preconception or during pregnancy allows identification of fetal risk for inherited autosomal recessive and X‐linked conditions. The goal is to identify at‐risk patients/couples and offer them reproductive options such as preimplantation genetic diagnosis, prenatal testing, or targeted newborn
Emily B. Rosenfeld, Nicole Kasatkin, Bi Liu Yu, Milen Velinov, Justin S. Brandt, Elena Ashkinadze   +5 more
wiley   +1 more source

Comparison the Effect of Letrozole Versus Medroxy Progesterone Acetate on Premenopausal Patients With Endometrial Hyperplasia: An Randomized clinical trial [PDF]

, 2017
Objective: The assessing the effect of letrozole and medroxyprogesterone acetate on women with simple endometrial hyperplasia without atypia in reproductive age.
Ahmadi, Shahnaz, Motamed, Niloofar, Rahmani, Elham, Safinejad, Fatemeh   +3 more
core   +1 more source

Uterine adenocarcinoma—A rare cause of chronic weight loss in mares

Veterinary Record Case Reports, Volume 14, Issue 2, May 2026.
Abstract Diagnosing the cause of slowly progressing weight loss in mares may be challenging, especially when only accompanied by non‐specific and weak clinical signs and non‐specific biochemical and haematological alterations. A 15‐year‐old mare presented with a history of weight loss, anorexia and fever.
Hanne Gervi Pedersen, Sanni Hansen, Anne Kirstine Havnsøe Krogh, Jørgen Steen Agerholm   +3 more
wiley   +1 more source

Port‐site hernia following laparoscopic gynecological surgery: A systematic review and meta‐analysis

Acta Obstetricia et Gynecologica Scandinavica, Volume 105, Issue 5, Page 778-794, May 2026.
This systematic review of 70 346 patients revealed an estimated incidence of port‐site hernia of 0.29%. Fascial closure reduces risk but does not eliminate port‐site hernia, and no specific closure technique shows clear superiority. Abstract Introduction Port‐site hernia (PSH) is a rare but clinically relevant complication of laparoscopic gynecologic ...
Franciszek Ługowski, Zofia Włodarczyk, Anna Owczarek, Łucja Zaborowska, Artur Ludwin   +4 more
wiley   +1 more source